Silo Pharma (SILO) announced its initial purchases of crypto tokens under its recently announced cryptocurrency treasury strategy targeting multi-chain asset growth. The Company’s acquisition of Ethereum and Solana tokens marks the first step toward incorporating cryptocurrency into its treasury holdings and lays the foundation for Silo’s broader blockchain and real world asset tokenization initiatives. The investment underscores the Company’s belief in the long-term value of digital assets and the potential of underlying blockchain technology to shape the future of biotechnology.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SILO:
- Psychedelic: Cybin completes enrollment in CYB004 Phase 2 study
- Silo Pharma announces Japanese patent for PTSD drug
- Psychedelic: Bright Minds reports preclinical BMB-201 results
- Silo Pharma secures Australian patent covering licensed PTSD drug candidate
- Psychedelic: NRx Pharmaceuticals reports Q2 earnings